• Mashup Score: 0

    Dear Colleague, On behalf of the ESPR, we would be grateful if you could dedicate 5 minutes to fill this short questionnaire regarding your experience about prophylactic use of hydrocortisone to prevent BPD and improve overall outcomes of our tiniest premies. This survey may be disseminated to your national neonatal society if you believe it could give us a more global picture of hydrocortisone…

    Tweet Tweets with this article
    • We would be grateful if you could dedicate 5 minutes to fill in this short questionnaire regarding your experience about prophylactic use of #hydrocortisone to prevent #BPD & improve overall outcomes of our tiniest #premies. #developingandapplyingresearch https://t.co/apwMNmQB7k

  • Mashup Score: 0

    Dear Colleague, On behalf of the ESPR, we would be grateful if you could dedicate 5 minutes to fill this short questionnaire regarding your experience about prophylactic use of hydrocortisone to prevent BPD and improve overall outcomes of our tiniest premies. This survey may be disseminated to your national neonatal society if you believe it could give us a more global picture of hydrocortisone…

    Tweet Tweets with this article
    • We would be grateful if you could dedicate 5 minutes to fill in this short questionnaire regarding your experience about prophylactic use of #hydrocortisone to prevent #BPD & improve overall outcomes of our tiniest #premies. #developingandapplyingresearch https://t.co/fgv9ZOXuza

  • Mashup Score: 0

    Dear Colleague, On behalf of the ESPR, we would be grateful if you could dedicate 5 minutes to fill this short questionnaire regarding your experience about prophylactic use of hydrocortisone to prevent BPD and improve overall outcomes of our tiniest premies. This survey may be disseminated to your national neonatal society if you believe it could give us a more global picture of hydrocortisone…

    Tweet Tweets with this article
    • We would be grateful if you could dedicate 5 minutes to fill in this short questionnaire regarding your experience about prophylactic use of #hydrocortisone to prevent #BPD & improve overall outcomes of our tiniest #premies 👉https://t.co/apwMNmQB7k #developingandapplyingresearch

  • Mashup Score: 0

    Hydrocortisone administered to extremely preterm infants who remained intubated at 14 to 28 days failed to improve survival without moderate or severe bronchopulmonary dysplasia at 36 weeks’ postmenstrual age compared with placebo.“In this multicenter, randomized, placebo-controlled trial involving infants at high risk for bronchopulmonary dysplasia, hydrocortisone treatment did not

    Tweet Tweets with this article
    • Among extremely preterm infants, #hydrocortisone failed to improve survival without moderate or severe #bronchopulmonarydysplasia compared with placebo @NEJM https://t.co/j3CqH8oUYm

  • Mashup Score: 0

    Hydrocortisone administered to extremely preterm infants who remained intubated at 14 to 28 days failed to improve survival without moderate or severe bronchopulmonary dysplasia at 36 weeks’ postmenstrual age compared with placebo.“In this multicenter, randomized, placebo-controlled trial involving infants at high risk for bronchopulmonary dysplasia, hydrocortisone treatment did not

    Tweet Tweets with this article
    • #ICYMI: New findings published in @NEJM found that compared with placebo, #hydrocortisone failed to improve survival without moderate or severe #bronchopulmonarydysplasia among extremely preterm infants @NEJM https://t.co/j3CqH8oUYm

  • Mashup Score: 0

    Hydrocortisone administered to extremely preterm infants who remained intubated at 14 to 28 days failed to improve survival without moderate or severe bronchopulmonary dysplasia at 36 weeks’ postmenstrual age compared with placebo.“In this multicenter, randomized, placebo-controlled trial involving infants at high risk for bronchopulmonary dysplasia, hydrocortisone treatment did not

    Tweet Tweets with this article
    • Among extremely preterm infants, #hydrocortisone failed to improve survival without moderate or severe #bronchopulmonarydysplasia compared with placebo @NEJM https://t.co/N2BgvVHqfC

    • Among extremely preterm infants, #hydrocortisone failed to improve survival without moderate or severe #bronchopulmonarydysplasia compared with placebo @NEJM https://t.co/I0qtXO4WDi